V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20221059 | 20084166 | 1.73 | 93.3 | Palliative (P) | null | 2019-03-12 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN + GEMCITABINE | 101087398 |
| 20221060 | 20084167 | 1.61 | 64 | Neo-adjuvant (N) | 2019-01-11 | 2019-01-18 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100118127 |
| 20221063 | 20084168 | 1.72 | 53.9 | Palliative (P) | 2019-04-16 | 2019-04-26 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101854984 |
| 20221064 | 20084169 | null | 68.2 | null | 2016-03-31 | 2016-04-07 | Capecitabine + Cisplatin + RT | 02 | null | CAPECITABINE + CISPLATIN + RT | 101068629 |
| 20221074 | 20084170 | 0 | 0 | Curative (C) | 2016-10-11 | 2016-10-19 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100921310 |
| 20221075 | 20084171 | 1.83 | 84.6 | Curative (C) | 2016-08-23 | 2016-08-23 | Cisplatin | 02 | N | OXALIPLATIN + RALTITREXED | 101731898 |
| 20221076 | 20084172 | 1.6 | 61.4 | Palliative (P) | 2019-12-19 | 2019-12-19 | Enzalutamide | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 101058672 |
| 20221079 | 20084173 | 1.59 | 68.9 | Palliative (P) | 2021-04-12 | 2021-04-12 | Enzalutamide | 02 | N | TRASTUZUMAB | 101699760 |
| 20221084 | 20084174 | 1.62 | 67.5 | Palliative (P) | 2018-12-08 | 2018-12-15 | Enzalutamide | 02 | N | OCTREOTIDE | 101218948 |
| 20221095 | 20084175 | 1.62 | 45.8 | Palliative (P) | 2016-06-23 | 2016-06-23 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | OXALIPLATIN + RALTITREXED | 101445003 |
| 20221096 | 20084176 | null | null | Curative (C) | 2016-02-18 | 2016-02-18 | Enzalutamide | 02 | Y | OXALIPLATIN + RALTITREXED | 101118497 |
| 20221103 | 20084177 | null | 62.8 | Neo-adjuvant (N) | 2016-05-08 | 2016-05-14 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101482232 |
| 20221104 | 20084178 | 1.75 | 67 | Palliative (P) | 2017-04-17 | 2017-04-18 | CETUXIMAB + OXALIPLATIN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100266547 |
| 20221107 | 20084179 | 1.62 | 76 | Neo-adjuvant (N) | 2018-04-06 | 2018-04-13 | Enzalutamide | 02 | Y | MITOMYCIN INTRAVESICULAR | 100869235 |
| 20221109 | 20084180 | 1.78 | 65 | Palliative (P) | 2017-11-26 | 2017-11-26 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100409253 |
| 20221110 | 20084181 | 1.41 | 82.1 | Palliative (P) | 2019-02-06 | 2019-02-20 | Enzalutamide | null | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101718312 |
| 20221112 | 20084182 | null | 82.7 | Palliative (P) | 2018-10-15 | 2018-11-13 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 101870159 |
| 20221113 | 20084183 | 1.7 | 85.9 | Curative (C) | 2016-04-19 | 2016-04-19 | Enzalutamide | 02 | N | OCTREOTIDE | 100028167 |
| 20221118 | 20084184 | 1.74 | 73.3 | null | 2017-01-23 | 2017-01-24 | OCTREOTIDE | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 100595490 |
| 20221122 | 20084185 | 0 | 66 | Palliative (P) | 2016-11-08 | 2016-11-09 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 100073488 |
| 20221123 | 20084186 | 0 | 0 | Palliative (P) | 2019-09-28 | 2019-10-15 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN + RT | 101807708 |
| 20221130 | 20084187 | 1.67 | 93.9 | Palliative (P) | 2017-04-08 | 2017-04-29 | Enzalutamide | 02 | N | MITOMYCIN INTRAVESICULAR | 100816709 |
| 20221136 | 20084188 | 1.84 | 59.8 | Neo-adjuvant (N) | 2017-01-13 | 2017-01-13 | OCTREOTIDE | 02 | Y | ECF | 101628177 |
| 20221140 | 20084189 | 1.59 | 68.2 | Curative (C) | 2017-02-15 | 2017-02-22 | Enzalutamide | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100709637 |
| 20221141 | 20084190 | 0 | 0 | Palliative (P) | 2018-10-06 | 2018-10-06 | Enzalutamide | 02 | N | OXALIPLATIN + RALTITREXED | 100545202 |
| 20221148 | 20084191 | 1.6 | 70 | Neo-adjuvant (N) | 2017-09-02 | 2017-09-02 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN + RT | 100887725 |
| 20221151 | 20084192 | 1.41 | 85.4 | Curative (C) | 2019-07-30 | 2019-08-11 | Enzalutamide | 02 | N | ECF | 101329686 |
| 20221153 | 20084193 | 1.6 | 45.8 | Palliative (P) | 2017-02-05 | 2017-02-10 | ATEZOLIZUMAB + BEVACIZUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101493919 |
| 20221158 | 20084194 | 1.67 | 54 | Palliative (P) | 2017-06-19 | 2017-06-20 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101123278 |
| 20221160 | 20084195 | 1.75 | 86.75 | Palliative (P) | 2020-03-02 | 2020-03-08 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 100619488 |
| 20221164 | 20084196 | 1.62 | 64 | Palliative (P) | 2019-02-15 | 2019-02-19 | Enzalutamide | null | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100078314 |
| 20221166 | 20084197 | 1.89 | 106.4 | Neo-adjuvant (N) | 2018-10-24 | 2018-10-27 | Enzalutamide | 02 | N | CARBOPLATIN | 100055350 |
| 20221170 | 20084198 | 1.69 | 92.6 | Palliative (P) | 2018-01-11 | 2018-01-11 | Enzalutamide | 2 | N | OXALIPLATIN + RALTITREXED | 100327769 |
| 20221185 | 20084199 | 1.59 | 69 | Curative (C) | 2017-02-02 | 2017-02-19 | Enzalutamide | 02 | null | CAPECITABINE + TEMOZOLOMIDE | 101382602 |
| 20221187 | 20084200 | null | 80 | Curative (C) | 2018-01-14 | 2018-01-14 | Enzalutamide | 2 | Y | MITOMYCIN INTRAVESICULAR | 100101027 |
| 20221190 | 20084201 | 1.6 | 56.4 | Curative (C) | 2017-02-26 | 2017-03-26 | Cetuximab 14 day | N | N | MITOMYCIN INTRAVESICULAR | 101722534 |
| 20221194 | 20084202 | 1.66 | 108 | Palliative (P) | 2017-08-26 | 2017-08-28 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN + RT | 101015774 |
| 20221204 | 20084203 | 1.71 | 94.5 | null | 2019-07-28 | 2019-07-29 | Enzalutamide | 02 | null | CETUXIMAB + OXALIPLATIN + MDG | 101356598 |
| 20221205 | 20084204 | 1.69 | 84 | Palliative (P) | null | 2019-03-16 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100796493 |
| 20221206 | 20084205 | 1.72 | null | Curative (C) | 2020-03-15 | 2020-03-22 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100237776 |
| 20221209 | 20084206 | 1.59 | 86.2 | Curative (C) | 2020-01-24 | 2020-01-28 | Enzalutamide | 2 | N | SCALOP-2 TRIAL | 100869122 |
| 20221210 | 20084207 | 1.83 | 63.3 | Neo-adjuvant (N) | 2018-09-09 | 2018-09-09 | Enzalutamide | 2 | N | CARBOPLATIN | 100661204 |
| 20221212 | 20084208 | 1.57 | 61.5 | Palliative (P) | 2016-02-21 | 2016-02-21 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101546181 |
| 20221214 | 20084209 | 0 | 0 | Curative (C) | 2016-06-28 | 2016-07-01 | Enzalutamide | N | N | CAPECITABINE + CISPLATIN + RT | 101169388 |
| 20221217 | 20084210 | 1.69 | 93 | Palliative (P) | 2016-04-30 | 2016-05-02 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100467776 |
| 20221219 | 20084211 | 1.57 | 59.6 | Palliative (P) | 2017-09-23 | 2017-10-06 | GEMCARBO | 02 | Y | CARBOPLATIN + GEMCITABINE | 100561679 |
| 20221224 | 20084212 | 1.71 | 83.1 | Curative (C) | 2018-03-10 | 2018-03-10 | Enzalutamide | N | Y | CAPECITABINE + CISPLATIN + RT | 101498227 |
| 20221227 | 20084213 | 1.57 | 56.7 | Palliative (P) | 2020-09-18 | 2020-09-26 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101582471 |
| 20221236 | 20084214 | 1.66 | 53 | null | 2019-08-24 | 2019-09-04 | Enzalutamide | N | Y | CAPECITABINE + TEMOZOLOMIDE | 101811393 |
| 20221255 | 20084215 | 1.62 | 114.1 | null | 2017-09-14 | 2017-09-28 | Enzalutamide | N | null | ATEZOLIZUMAB + BEVACIZUMAB | 100744231 |